Scientists are developing a smartphone app that they say can accurately detect Down syndrome in infants soon after birth. Down syndrome, a genetic disorder that affects about 1-in-1,000 children worldwide, causes physical and intellectual disabilities. Early detection is beneficial to the development of children with the disorder, but that requires sophisticated medical tests not available everywhere. In developed countries, Down syndrome is often detected during prenatal screenings. But in less-developed countries, these tests are often not available. Marius Linguraru, a principal investigator at Washington’s Sheikh Zayed Institute for Pediatric Surgical Innovation, said genetic defects can be hard to diagnose after a baby is born.
Full Photo Gallery
Want the latest Children's National news and stories as they happen? Sign up to get our News & Events releases by email.
A study by researchers at Children’s National Health System provides direct evidence that targeting specific receptors in white matter cells after brain injury promotes cellular and functional recovery.
In a feature story in Bloomberg Businessweek about Duchenne muscular dystrophy, Eric Hoffman, PhD, discusses the current tension that exists between families and drug regulators.
A study published in the Journal of the American Medical Association showed that lorazepam - a widely used but not FDA approved drug for children - is no more effective than diazepam for treating pediatric seizures.
Researchers at Children's National conducted a study which found that African American children with a genetic predisposition to diabetes may be able to reduce their risk by getting the USDA-recommended dose of calcium.